JP2005506047A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506047A5
JP2005506047A5 JP2002575309A JP2002575309A JP2005506047A5 JP 2005506047 A5 JP2005506047 A5 JP 2005506047A5 JP 2002575309 A JP2002575309 A JP 2002575309A JP 2002575309 A JP2002575309 A JP 2002575309A JP 2005506047 A5 JP2005506047 A5 JP 2005506047A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleotides
sequence
seq
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002575309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506047A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/009611 external-priority patent/WO2002077267A2/en
Publication of JP2005506047A publication Critical patent/JP2005506047A/ja
Publication of JP2005506047A5 publication Critical patent/JP2005506047A5/ja
Pending legal-status Critical Current

Links

JP2002575309A 2001-03-27 2002-03-27 膜貫通型セリンプロテアーゼ9をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法 Pending JP2005506047A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27922801P 2001-03-27 2001-03-27
US29150101P 2001-05-15 2001-05-15
PCT/US2002/009611 WO2002077267A2 (en) 2001-03-27 2002-03-27 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon

Publications (2)

Publication Number Publication Date
JP2005506047A JP2005506047A (ja) 2005-03-03
JP2005506047A5 true JP2005506047A5 (cg-RX-API-DMAC7.html) 2005-09-02

Family

ID=26959537

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002575309A Pending JP2005506047A (ja) 2001-03-27 2002-03-27 膜貫通型セリンプロテアーゼ9をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法

Country Status (7)

Country Link
US (1) US7105333B2 (cg-RX-API-DMAC7.html)
EP (1) EP1379637A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005506047A (cg-RX-API-DMAC7.html)
KR (1) KR20030096292A (cg-RX-API-DMAC7.html)
CA (1) CA2442089A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ527971A (cg-RX-API-DMAC7.html)
WO (1) WO2002077267A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784746B2 (en) 1999-11-18 2006-06-08 Dendreon Corporation Nucleic acids encoding endotheliases, endotheliases and uses thereof
US7700341B2 (en) * 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
WO2002072786A2 (en) 2001-03-13 2002-09-19 Corvas International, Inc. Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
US7172892B2 (en) 2001-03-22 2007-02-06 Dendreon Corporation Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
JP2005506047A (ja) 2001-03-27 2005-03-03 デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー 膜貫通型セリンプロテアーゼ9をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法
US7112430B2 (en) 2001-05-14 2006-09-26 Dendreon Corporation Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
US20040001801A1 (en) * 2002-05-23 2004-01-01 Corvas International, Inc. Conjugates activated by cell surface proteases and therapeutic uses thereof
ATE457353T1 (de) 2003-11-28 2010-02-15 Univ Sydney Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
MX2008004693A (es) 2005-10-21 2008-09-03 Catalyst Biosciences Inc Proteasas modificadas que inhiben la activacion del complemento.
CN103289980A (zh) 2006-07-05 2013-09-11 催化剂生物科学公司 蛋白酶筛选方法及由此鉴别的蛋白酶
ES2550754T3 (es) * 2007-08-07 2015-11-12 Oxford Biotherapeutics Ltd. Proteína matriptasa y usos de la misma
TWI538916B (zh) 2008-04-11 2016-06-21 介控生化科技公司 經修飾的因子vii多肽和其用途
EP3461496B1 (en) * 2009-06-22 2023-08-23 Wyeth LLC Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
CN105849127A (zh) 2013-11-25 2016-08-10 牛津生物疗法有限公司 用于治疗癌症的抗间质蛋白酶抗体
MA41374A (fr) * 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
JP7091373B2 (ja) 2017-06-22 2022-06-27 カタリスト・バイオサイエンシーズ・インコーポレイテッド 改変された膜型セリンプロテアーゼ1(mtsp-1)ポリペプチドおよび使用方法
US20210069306A1 (en) 2019-08-15 2021-03-11 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration and on-demand treatment

Family Cites Families (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US143219A (en) * 1873-09-30 Improvement in separators for coal, ores
US119168A (en) * 1871-09-19 Improvement in fur-boxes
US19006A (en) * 1857-12-29 Paint compound
US134298A (en) * 1872-12-24 Improvement in raiiway
US1801A (en) * 1840-10-08 Construction of self-acting mules fob
US50251A (en) * 1865-10-03 Improved apparatus for carbureting air
US64856A (en) * 1867-05-21 Daniel fobes
US134794A (en) * 1873-01-14 Improvement in leather punches and cutters
US186329A (en) * 1877-01-16 Improvement in buckles
US181658A (en) * 1876-08-29 Improvement in straw-cutters
US170630A (en) * 1875-11-30 Improvement in spinning-wheels
US235900A (en) * 1880-12-28 Buo kel
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
GB1319315A (en) 1969-06-19 1973-06-06 Citizen Watch Co Ltd Calendar timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4006117A (en) 1973-01-24 1977-02-01 Hooker Chemicals & Plastics Corporation Amine phosphite antioxidants
US3843443A (en) 1973-03-30 1974-10-22 J Fishman Polypeptide materials bound to fluorocarbon polymers
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4244721A (en) 1979-01-31 1981-01-13 Pedro Buarque De Macedo Method of making composite borosilicate glass articles
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4507230A (en) 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US4769027A (en) 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4778767A (en) 1984-12-17 1988-10-18 Akzo N.V. Solid phase immunoassay using immunoreagents immobilized on inert synthetic resin surfaces
DE3500180A1 (de) 1985-01-04 1986-07-10 Ernst Prof. Dr. 7400 Tübingen Bayer Pfropfcopolymerisate aus vernetzten polymeren und polyoxyethylen, verfahren zu ihrer herstellung und ihre verwendung
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4687610A (en) 1986-04-30 1987-08-18 E. I. Du Pont De Neumours And Company Low crystallinity polyester yarn produced at ultra high spinning speeds
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4902505A (en) 1986-07-30 1990-02-20 Alkermes Chimeric peptides for neuropeptide delivery through the blood-brain barrier
DE3626468A1 (de) 1986-08-05 1988-02-11 Hoechst Ag Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5071773A (en) 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US5292814A (en) 1987-04-29 1994-03-08 Ernst Bayer Process for the preparation of monodispersed polymer beads
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
AU618640B2 (en) 1988-11-11 1992-01-02 Boehringer Mannheim Gmbh Process for the expression of a recombinant gene
US5304482A (en) 1989-03-06 1994-04-19 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors
US5550042A (en) 1989-03-06 1996-08-27 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
DK0462207T3 (da) 1989-03-06 2001-06-18 Univ Texas t-Pa mutanter resistente mod deres respektive inhibitorer
US5866413A (en) 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
AU5554190A (en) 1989-05-08 1990-11-29 Mark I. Farber Process and apparatus for the recovery of precious metals from slag, tailings and other materials
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5215899A (en) 1989-11-09 1993-06-01 Miles Inc. Nucleic acid amplification employing ligatable hairpin probe and transcription
US5861274A (en) 1990-03-22 1999-01-19 The Salk Institute For Biological Studies Nucleic acids encoding peroxisome proliferator-activated receptor
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5256643A (en) 1990-05-29 1993-10-26 The Government Of The United States Human cripto protein
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
AU660629B2 (en) 1990-10-01 1995-07-06 University Of Connecticut, The Targeting viruses and cells for selective internalization by cells
CA2099574A1 (en) 1991-01-04 1992-07-05 Noubar B. Afeyan Sulfonamide bonded hydrophilic coatings
AU668870B2 (en) 1991-05-14 1996-05-23 Targetech, Inc Targeted delivery of genes encoding immunogenic proteins
DE69231385T2 (de) 1991-06-05 2001-04-12 The Board Of Regents Acting For And On Behalf Of The Unversity Of Michigan, Ann Arbor Zielgerichtete freisetzung von genen, die sekretorische proteine kodieren
AU2579692A (en) 1991-09-17 1993-04-27 Salk Institute For Biological Studies, The Receptor of the thyroid/steroid hormone receptor superfamily
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
AU3434393A (en) 1992-01-17 1993-08-03 Regents Of The University Of Michigan, The Targeted virus
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
JPH07505773A (ja) 1992-04-03 1995-06-29 ヤング アレキサンダー ティー 標的化されたウイルスベクターを用いた遺伝子治療
PT644771E (pt) 1992-06-11 2002-12-31 Alkermes Inc Sistema de entrega da droga eritropoietina
WO1994005807A1 (en) 1992-08-28 1994-03-17 Dickson Robert B Matrix-degrading metalloproteinase
KR950703640A (ko) 1992-10-09 1995-09-20 가일 케이,나우톤. 간 보존 세포(liver reserve cells)
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5354934A (en) 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
US5354566A (en) 1993-06-02 1994-10-11 Kraft General Foods, Inc. Preparation of yeast-leavened dough crusts
EP1157743B1 (en) 1993-10-28 2009-03-11 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
IL112759A0 (en) 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
US5612474A (en) 1994-06-30 1997-03-18 Eli Lilly And Company Acid labile immunoconjugate intermediates
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
DE69505076T2 (de) 1994-07-29 1999-02-25 Teijin Ltd., Osaka Trypsintyp-Enzyme, dafür kodierende Nukleinsäuresequenz und Verfahren zur Herstellung des Enzymes
US5589154A (en) 1994-11-22 1996-12-31 Rutgers, The State University Of New Jersey Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
CZ298197A3 (cs) 1995-03-24 1998-03-18 Arris Pharmaceutical Corporation Reverzibilní inhibitory proteas
US5767174A (en) 1995-05-25 1998-06-16 Asahi Glass Company, Ltd. Vinyl chloride resin composition
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5795872A (en) 1995-09-19 1998-08-18 Pharmadigm, Inc. DNA construct for immunization
ATE377006T1 (de) 1995-11-28 2007-11-15 Cephalon Inc Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
CA2241051A1 (en) 1995-12-21 1997-10-23 The Scripps Research Institute Targeted therapeutic or diagnostic agents and methods of making and using same
DE69731226T2 (de) 1996-06-10 2006-03-09 The Scripps Research Institute, La Jolla Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
WO2000053756A2 (en) 1999-03-08 2000-09-14 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2001505765A (ja) 1996-11-12 2001-05-08 ザ スクリプス リサーチ インスティテュート 組織型プラスミノーゲンアクチベーター(t―PA)の変異体:組成物およびその使用方法
WO1998032619A1 (fr) 1997-01-27 1998-07-30 Alain Bonnet Dispositif d'attelage d'un vehicule a bras porteur de charge sur un vehicule routier, et vehicule a bras destine a cette application
US6150378A (en) 1997-10-07 2000-11-21 Cephalon, Inc. Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
US6203979B1 (en) 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
US6323332B1 (en) 1998-01-21 2001-11-27 The Burnham Institute Sulfotransferase for HNK-1 glycan
US5972616A (en) 1998-02-20 1999-10-26 The Board Of Trustees Of The University Of Arkansas TADG-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas
NZ507435A (en) 1998-03-10 2003-12-19 Genentech Inc Novel polypeptides and nucleic acids with homology to cornichon
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
NZ531664A (en) 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
AU3223100A (en) 1999-02-05 2000-08-25 Alphagene, Inc. Proteomic interaction arrays
AU1068900A (en) 1999-02-26 2000-09-14 Ohio State University Research Foundation, The Detecting the expression of the desc1 gene in squamous cell carcinoma
US6291663B1 (en) 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
WO2000055124A2 (en) 1999-03-15 2000-09-21 Axys Pharmaceuticals, Inc. Novel compounds and compositions as protease inhibitors
US20030186329A1 (en) 1999-03-22 2003-10-02 The Scripps Research Institute Use of substrate subtraction libraries to distinguish enzyme specificities
CA2373759A1 (en) 1999-05-07 2000-11-16 Human Genome Sciences, Inc. Serine proteases
US20030175938A1 (en) 1999-05-07 2003-09-18 Human Genome Sciences, Inc. Serine protease polynucleotides, polypeptides, and antibodies
AU2883700A (en) 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003506017A (ja) 1999-07-12 2003-02-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング セリパンクリン
US20020165376A1 (en) 1999-12-22 2002-11-07 Walke D. Wade Novel human proteases and polynucleotides encoding the same
WO2001027624A2 (en) 1999-10-08 2001-04-19 Superarray, Inc. Compositions and methods for detecting protein modification and enzymatic activity
JP2003516124A (ja) 1999-10-15 2003-05-13 ユニバーシティー オブ マサチューセッツ 標的とした遺伝的干渉の手段としてのrna干渉経路遺伝子
US20030077697A1 (en) * 1999-11-17 2003-04-24 Gerlach Valerie L. Novel serine/threonine protein-kinase like proteins and nucleic acids encoding the same
JP2003533174A (ja) 1999-11-17 2003-11-11 キュラジェン コーポレイション 新規なポリペプチドおよびこのポリペプチドをコードする核酸
AU784746B2 (en) 1999-11-18 2006-06-08 Dendreon Corporation Nucleic acids encoding endotheliases, endotheliases and uses thereof
AU1624801A (en) 1999-11-19 2001-05-30 Corvas International, Inc. Plasminogen activator inhibitor antagonists related applications
EP1244795A1 (en) 2000-01-06 2002-10-02 Lexicon Genetics Incorporated Novel human proteases and polynucleotides encoding the same
AU2001233041A1 (en) 2000-01-25 2001-08-07 Hyseq, Inc. Novel nucleic acids and polypeptides
CA2395838A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001055447A1 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1252300B1 (en) 2000-02-03 2011-01-19 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
US6797504B1 (en) 2000-09-08 2004-09-28 Dendreon San Diego Llc Inhibitors of serine protease activity of matriptase or MTSP1
US7700341B2 (en) 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU6802801A (en) 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001271427A1 (en) 2000-06-26 2002-01-08 Sugen, Inc. Novel proteases
JP2004504026A (ja) * 2000-07-18 2004-02-12 バイエル アクチェンゲゼルシャフト ヒトdesc1様セリンプロテアーゼの調節
US20020068702A1 (en) 2000-07-21 2002-06-06 Marguerita Lim-Wilby Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
RU2003105221A (ru) 2000-07-21 2004-09-20 Шеринг Корпорейшн (US) Новые пептиды, как ингибиторы ns3-серинпротеазы вируса гепатита с
WO2002008396A2 (en) 2000-07-21 2002-01-31 Incyte Genomics, Inc. Human proteases
NZ547626A (en) 2000-08-11 2007-10-26 Wilex Ag Non-covalent inhibitors of urokinase and blood vessel formation
ATE517910T1 (de) 2000-08-11 2011-08-15 Wilex Ag NICHT-KOVALENTE INHIBITOREN VON UROKINASE UND BLUTGEFÄßBILDUNG
US7157596B2 (en) 2000-09-08 2007-01-02 Dendreon Corporation Inhibitors of serine protease activity of matriptase or MTSP1
US6365391B1 (en) * 2000-09-27 2002-04-02 Pe Corporation (Ny) Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof
WO2002048097A1 (en) 2000-12-12 2002-06-20 Corvas International, Inc. Compounds, compositions and methods for treatment of parasitic infections
US20030170630A1 (en) 2000-12-21 2003-09-11 Alsobrook John P. Proteins and nucleic acids encoding same
WO2002072786A2 (en) 2001-03-13 2002-09-19 Corvas International, Inc. Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
US7172892B2 (en) 2001-03-22 2007-02-06 Dendreon Corporation Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
JP2005506047A (ja) 2001-03-27 2005-03-03 デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー 膜貫通型セリンプロテアーゼ9をコード化する核酸分子、コード化されたポリペプチドおよびそれらに基づく方法
US7112430B2 (en) 2001-05-14 2006-09-26 Dendreon Corporation Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
KR20040004642A (ko) 2001-05-23 2004-01-13 덴드레온 샌 디에고 엘엘씨 세포 표면 프로테아제에 의해 활성화되는 접합체 및 이의치료학적 용도
WO2003004681A2 (en) 2001-07-03 2003-01-16 Dendreon San Diego Llc Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon
WO2003031585A2 (en) 2001-10-09 2003-04-17 Dendreon Corporation Transmembrane serine protease 25
WO2003044179A2 (en) 2001-11-20 2003-05-30 Dendreon San Diego Llc Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
AU2002367968A1 (en) 2001-11-29 2003-12-22 Wyeth Holdings Corporation Antibacterial targets in alloiococcus otitidis
US20040001801A1 (en) 2002-05-23 2004-01-01 Corvas International, Inc. Conjugates activated by cell surface proteases and therapeutic uses thereof
AU2003247776A1 (en) 2002-07-02 2004-01-23 Dendreon Corporation Serine protease 16
JP2006047451A (ja) 2004-08-02 2006-02-16 Kawai Musical Instr Mfg Co Ltd 電子楽器

Similar Documents

Publication Publication Date Title
JP2005506047A5 (cg-RX-API-DMAC7.html)
EP2547698B1 (en) Methods of determining susceptibility of tumors to tyrosine kinase inhibitors
WO1999033963A1 (en) Metastatic cancer regulated gene
JP2004535166A5 (cg-RX-API-DMAC7.html)
US20060179496A1 (en) Nucleic acid sequences differentially expressed in cancer tissue
EA013617B1 (ru) Мутации рецептора эпидермального фактора роста
JP2007537197A5 (cg-RX-API-DMAC7.html)
US7291492B2 (en) Histone deacetylase 9
US11726087B2 (en) Methods, compositions, and kits for detection of aspergillosis
KR20070073802A (ko) Wnt 단백질 및 암의 검출 및 치료
US8288094B2 (en) APOBEC3 mediated DNA editing
US7211398B2 (en) Human genes and gene expression products: II
CN115707784A (zh) Usp10在非小细胞肺癌患者的诊断和预后评估中的应用
US6544742B1 (en) Detection of genes regulated by EGF in breast cancer
WO2006014903A2 (en) Compositions and methods of use for adam12 antagonists in treating disease
AU2008357875A1 (en) Interferon Epsilon (IFNE1) as a marker for targeted cancer therapy
US20220363767A1 (en) Hla-h, hla-j, hla-l, hla-v and hla-y as therapeutic and diagnostic targets
KR100577318B1 (ko) Mic-1 유전자의 억제제를 함유하는 위암 치료제, 위암진단방법 및 진단킷트
JP6446700B2 (ja) ニューレグリン−1(Neuregulin−1)部分ペプチド
JP2005046137A (ja) 新規ヒト遺伝子および遺伝子発現産物
WO2023009985A1 (en) Compositions and methods for in vivo protease profiling by immune cell display
US20070298022A1 (en) Identification of Phospholipase A2 as Target in Cancer Treatment, with Special Emphasis on Colorectal Cancer and Its Mechanism of Action
JP2006516888A5 (cg-RX-API-DMAC7.html)
KR102110338B1 (ko) 대장암 진단 마커로서의 신규 folr2 융합유전자 및 이의 용도
RU2002120920A (ru) Молекулы нуклеиновых кислот, кодирующие трансмембранные сериновые протеазы, кодируемые белки и способы их использования